Phase II study of induction chemotherapy with gemcitabine and carboplatin (IndGC) followed by paclitaxel and carboplatin with concurrent thoracic radiation (PCRT) for patients with unresectable stage III non-small-cell lung cancer (NSCLC): MCC-13240
2005 ◽
Vol 23
(16_suppl)
◽
pp. 7307-7307
Keyword(s):
Phase Ii
◽